Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Change in Taxes (2023 - 2025)

Historic Change in Taxes for Gyre Therapeutics (GYRE) over the last 3 years, with Q3 2025 value amounting to $1.5 million.

  • Gyre Therapeutics' Change in Taxes rose 18710.28% to $1.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$152000.0, marking a year-over-year increase of 9370.86%. This contributed to the annual value of -$2.2 million for FY2024, which is 17212.79% down from last year.
  • According to the latest figures from Q3 2025, Gyre Therapeutics' Change in Taxes is $1.5 million, which was up 18710.28% from $513000.0 recorded in Q2 2025.
  • In the past 5 years, Gyre Therapeutics' Change in Taxes ranged from a high of $2.5 million in Q3 2023 and a low of -$4.2 million during Q2 2024
  • In the last 3 years, Gyre Therapeutics' Change in Taxes had a median value of $513000.0 in 2025 and averaged $56363.6.
  • Within the past 5 years, the most significant YoY rise in Gyre Therapeutics' Change in Taxes was 18710.28% (2025), while the steepest drop was 25924.1% (2025).
  • Quarter analysis of 3 years shows Gyre Therapeutics' Change in Taxes stood at -$185000.0 in 2023, then skyrocketed by 135.14% to $65000.0 in 2024, then soared by 2263.08% to $1.5 million in 2025.
  • Its Change in Taxes was $1.5 million in Q3 2025, compared to $513000.0 in Q2 2025 and -$2.3 million in Q1 2025.